Primary study · included by 1 review
Impact of the use of Kampo medicine in patients with esophageal cancer during chemotherapy:a clinical trial for oral hygiene and oral condition.
Moriyama 2018 · Moriyama Satomi, Hinode Daisuke, Yoshioka Masami, et al. · The journal of medical investigation : JMI · 2018
Included by
| Outcome this study informs | Pooled effect | Evidence | Certainty |
|---|---|---|---|
Chemotherapy-induced oral mucositis (grade 2 or higher by CTCAE v5.0, described as more than grade 1) Hangeshashinto (TJ-14) during chemotherapy vs No hangeshashinto or placebo | RR 0.86 [0.73, 1.00] | 6 studies · 293 participants | Moderate |
Chemotherapy-induced oral mucositis (grade 2 or higher by CTCAE v5.0, described as more than grade 1) Hangeshashinto (TJ-14) during chemotherapy vs No hangeshashinto or placebo | RR 0.90 [0.67, 1.21] | 4 studies | GRADE not reported |
Chemotherapy-induced oral mucositis (grade 2 or higher by CTCAE v5.0, described as more than grade 1) Hangeshashinto (TJ-14) during chemotherapy vs No hangeshashinto or placebo | RR 0.81 [0.56, 1.17] | 2 studies | GRADE not reported |
1 including review in total.